En Español | Plain Text Version | Skip Navigation

You are here:  Home > Disorders > Acid Lipase Disease

NINDS Acid Lipase Disease Information Page

Skip secondary menu

Synonym(s):   Cholesterol Ester Storage Disease, Wolman’s Disease

Table of Contents (click to jump to sections)
What is Acid Lipase Disease ?
Is there any treatment?
What is the prognosis?
What research is being done?

Related NINDS Publications and Information

What is Acid Lipase Disease ?

Acid lipase disease occurs when the enzyme needed to break down certain fats that are normally digested by the body is lacking or missing, resulting in the toxic buildup of these fats in the body’s cells and tissues.  These fatty substances, called lipids, include waxes, oils, and cholesterol.  Two rare lipid storage diseases are caused by the deficiency of the enzyme lysosomal acid lipase:

 

Wolman’s disease is an autosomal recessive disorder marked by the buildup of cholesteryl esters (normally a tranport form of cholesterol that brings nutrients into the cells and carries out waste) and triglycerides (a chemical form in which fats exist in the body).  Infants with the disorder appear normal at birth but quickly develop progressive mental deterioration, low muscle tone, jaundice, anemia, vomiting, malnourishment, gastrointestinal problems, and calcium deposits in the adrenal glands, causing them to harden.  Affected children also develop an enlarged liver and grossly enlarged spleen, and the abdomen is distended.  Both male and female infants are affected by the disorder.

 

Cholesteryl ester storage disease (CESD) is an extremely rare disorder that results from storage of cholesteryl esters and triglycerides in cells in the blood and lymph and lymphoid tissue.  CESD is a less severe variant of Wolman’s disease, with later onset.  Children develop an enlarged liver, leading to cirrhosis and chronic liver failure before adulthood.  Children may also develop calcium deposits in the adrenal glands and jaundice.  Onset varies, and the disorder may not be diagnosed until adulthood.

Is there any treatment?

There is no specific treatment for Wolman’s disease or CESD.  Certain drugs may be given to help with adrenal gland production, and children may need to be fed intravenously.  Individuals with CESD may benefit from a low cholesterol diet.

What is the prognosis?

Infants with Wolman’s disease usually die by age 1 from malnutrition.  The onset and course of CESD varies, and individuals may live into adulthood.

What research is being done?

The National Institute of Neurological Disorders and Stroke (NINDS), a part of the National Institutes of Health, conducts and funds research to better understand lipid storage diseases such as Wolman’s disease and CESD.  Other researchers are studying the effects of bone marrow or umbilical cord blood transplantation in children with storage diseases and are trying to identify the candidate genes that cause such disorders.

 

The National Library of Medicine (NLM), a part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services, offers free searches of biomedical literature through an Internet service called PubMed.  To search, go to:  http://www.ncbi.nlm.nih.gov/PubMed .  The NLM also offers extensive health information from NIH and other trusted sources.  To research your condition, go to:  http://www.medlineplus.gov .

 

Select this link to view a list of studies currently seeking patients.

Related NINDS Publications and Information


Prepared by:
Office of Communications and Public Liaison
National Institute of Neurological Disorders and Stroke
National Institutes of Health
Bethesda, MD 20892



NINDS health-related material is provided for information purposes only and does not necessarily represent endorsement by or an official position of the National Institute of Neurological Disorders and Stroke or any other Federal agency. Advice on the treatment or care of an individual patient should be obtained through consultation with a physician who has examined that patient or is familiar with that patient's medical history.

All NINDS-prepared information is in the public domain and may be freely copied. Credit to the NINDS or the NIH is appreciated.

Return to top

Last updated August 13, 2008